French translation and validation of the cross-cultural adaptation of the MSTS functional assessment questionnaire completed after tumor surgery - 23/04/23
, Monia El Kinani a, Vincent Crenn a, b, Peggy Ageneau a, Juliane Berchoud a, Yoann Varenne a, Denis Waast a, Louis Romée Le Nail c, Jean-Benoit Hardouin d, e, Francois Gouin a, f, Kevin Brulefert a, b
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Abstract |
Introduction |
Malignant tumors of the extremities are uncommon. Their surgical treatment, whether conservative or not, may cause sequelae. Functional assessment of patients is essential for research purposes, but also follow-ups and adaptation of treatments. The Musculoskeletal Tumor Society Rating Scale (MSTS) is a disease-specific functional scoring system often used in English literature. Currently, no studies have been published on a valid French translation of the MSTS, whether for the lower or upper extremities. We, therefore, conducted a prospective study to answer the following questions: (1) Are the proposed adapted French versions of the MSTS valid? (2) Do the psychometric properties of the two versions obtained make their use relevant?
Materials and methods |
The translation and cross-cultural adaptation were carried out following the recommendations of Beaton and Guillemin to obtain two versions: one for patients who had undergone upper extremity surgery (MSTS-UE) and one for those who had undergone lower extremity surgery (MSTS-LE). A prospective multicenter cohort study was then carried out to analyze the psychometric properties of these two versions.
Results |
A total of 250 patients from 3 referral centers were enrolled in this study. A confirmatory factor analysis (CFA) demonstrated that the two French versions of the MSTS (MSTS-LE and MSTS-UE) were a good fit with a root mean square error of approximation (RMSEA)<0.08 and a comparative fit index (CFI)>0.90. The psychometric properties of the two versions were validated with internal consistency (Cronbach alpha>0.7), convergent validity of each item with its score (> 0.4), and sufficient criterion validity (Pearson correlation coefficient>0.4). The discriminant validity analysis showed that there was a significant correlation between each version and the performance status (PS) (p<0.05).
Conclusion |
This study produced a French version of the MSTS scoring system and validated the psychometric properties of the two versions obtained (MSTS-UE and MSTS-LE). Therefore, the French MSTS scoring system is a valid measurement that can be used in international studies.
Level of evidence |
I.
El texto completo de este artículo está disponible en PDF.Keywords : Cross-cultural validation, Musculoskeletal tumor society scoring system, French translation, Clinician-reported outcome, Sarcoma
Esquema
Vol 109 - N° 3
Artículo 103574- mai 2023 Regresar al número
Artículo precedente
- Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities
- Tugba Akin Telli, Ozkan Alan, Nazim Can Demircan, Nisanur Sariyar, Rukiye Arikan, Tugba Basoglu, Alper Yasar, Abdussamet Celebi, Selver Isik, Omer Sofulu, Bulent Erol, Huseyin Kemal Turkoz, Zerrin Ozgen, Ozlem Ercelep, Faysal Dane, Perran Fulden Yumuk
- Epiphyseal-sparing biological reconstruction of bone sarcoma in children: Focus on articular function and growth
- Sébastien Raux, Coline Ducrot, Perrine Marec-Bérard, Nadège Corradini, Line Claude, Frédérique Dijoud, Cécile Picard, Amine Bouhamama, Franck Chotel
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.